Prof. Richard Moreau has received a special award from the French Association for the Study of the Liver (AFEF). The “Prix spécial francophone pour l’Etude de l’Hypertension Portale” was awarded to Prof. Moreau for his study of portal hypertension. Prof.…
We are happy to announce the launch of the new EASL member zone designed to improve your experience as an EASL member. You will now find it easier to: Create your profile information and photo Choose what information is visible…
Visit the new ILC 2020 website to find out the latest information about The International Liver Congress™ 2020. At ILC 2020, EASL is turning its attention to health in daily life and its importance in protecting the liver. Doctors, patients…
Is non-alcoholic fatty liver disease the next public health crisis? After singer George Michael passed away in 2016, the coroner's report listed fatty liver disease as one of the causes of death. This was probably the first time the British…
"Save the date! ELPA announces ELPA Pre-Summit on NAFLD – information for and from patients, patient experiences and views on NAFLD, as a back to back event to EASL NAFLD Summit on 26th September 2019 in Seville, Spain. As times…
Modules 3 and 4 of the EASL/EFSUMB Ultrasound of the Liver course are now available on EASL Campus. Module 3 – Focal liver lesions; the liver and biliary system Course description: The third module of the EASL/EFSUMB Basics of Ultrasound…
EASL’s goal is to pursue and facilitate excellence in liver research, clinical practice of liver disorders, and the provision of education to all those interested in hepatology. This requires recognizing and supporting excellence regardless of gender, ethnicity, nationality, disability, religion,…
The HCC: Management of the side effects of immune checkpoint inhibitors course* is now available on EASL Campus. Course description : In this fascinating discussion, four of the leading experts in the field of hepatocellular carcinoma (HCC) discuss the use of…
The Lancet-EASL Commission is tackling liver diseases in Europe and overcoming unmet needs, stigma and inequities. The Commission is quantifying the burden of liver disease in Europe and addressing optimal diagnosis and standards of care for patients with liver diseases…
A pioneering European research project, designed to develop new diagnostic tests to assess patients with Non-Alcoholic Fatty Liver Disease (NAFLD) has expanded giving access to more patients. Incorporating several new partners also enables access to even more state-of-the art technologies.…